Brand family
Trijardy XR
Empagliflozin, Linagliptin and Metformin · Boehringer Ingelheim Pharmaceuticals
United States
- Presentations
- 4
- Markets
- 1
Trijardy XR is a brand of Empagliflozin, Linagliptin and Metformin marketed by Boehringer Ingelheim Pharmaceuticals, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Empagliflozin, Linagliptin and Metformin
- Brand owner
- Boehringer Ingelheim Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 10 mg/5 mg/1000 mg extended-release tablet, 12.5 mg/2.5 mg/1000 mg extended-release tablet, 25 mg/5 mg/1000 mg extended-release tablet, 5 mg/2.5 mg/1000 mg extended-release tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Trijardy XR 10 mg/5 mg/1000 mg extended-release tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
| Trijardy XR 12.5 mg/2.5 mg/1000 mg extended-release tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
| Trijardy XR 25 mg/5 mg/1000 mg extended-release tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
| Trijardy XR 5 mg/2.5 mg/1000 mg extended-release tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Trijardy XR
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.